Alliance Global Partners reiterated coverage on Immutep with a new price target

1/26/21 7:29:17 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Alliance Global Partners reiterated coverage of Immutep with a rating of Buy and set a new price target of $6.00 from $5.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$IMMP

Date	Price Target	Rating	Analyst
5/17/2024	$10.00	Overweight	CapitalOne
8/3/2023	$7.00	Outperform	Robert W. Baird
8/3/2021	$8.30	Buy	Ladenburg Thalmann
7/16/2021	$8.00	Buy	Maxim Group